<< Back injury can set you on your back and set you back financially | MetLife data indicates middle boomers should be treated as separate demographic groups >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | Norsk

25th Alzheimer's Disease International conference: Focus on new treatment developments

Published on March 4, 2010 at 6:24 AM · No Comments

"What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

Sam Gandy, M.D., Ph.D. of Mount Sinai Alzheimer's Disease Research Center, New York, will address "New Treatment Developments" in Alzheimer's, including therapies that have the greatest potential for entering clinical practice in the next few years - bapineuzumab, latrepirdine, and gamma secretase inhibitors. He also will touch on intriguing science that may explain the link between Alzheimer's and diabetes.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading